We also analyzed intrahepatic expression levels of the MIF receptors (CD74, CXCR2 and CXCR4) in NASH patients, but could not detect a significant alteration, when stratifying patients according to fibrosis grade (Figure 1D–F). The gene discussed is CXCR4; the disease is metabolic dysfunction-associated steatohepatitis.